Intel’s wild week leaves Wall Street more uncertain than ever about chipmaker’s future
Intel CEO Patrick Gelsinger speaks at the Intel Ocotillo Campus in Chandler, Arizona, on March 20, 2024. Brendan Smialowski | AFP ...
Tag: Business
Boeing’s defense unit chief Colbert is departing, CEO says
Former CEO for Boeing's defense, space and security subdivision Ted Colbert speaks during a press conference in Dubai on Nov. ...
UAW warns of potential strikes at Ford, Stellantis a year after unprecedented work stoppages
UAW president Shawn Fain and members and workers at the Mopar Parts Center Line, a Stellantis Parts Distribution Center in ...
WNBA to add expansion team in Portland, bringing league to 15 franchises
WNBA expansion team coming to Portland in 2026.Source: WNBAThe WNBA is adding its 15th team in Portland, the third new ...
Alaska-Hawaiian merger clears DOT review, but airlines must preserve miles, routes
Alaska Airlines and Hawaiian Airlines can go through with their planned merger, but they must maintain the value of their ...
Tech M&A has been thwarted by regulators, but dealmakers skeptical that election will change much
Lina Khan, chair of the U.S. Federal Trade Commission, and Jonathan Kanter, assistant attorney general for the Justice Department's antitrust ...
Jeep CEO enacts turnaround plan after significant sales declines
Jeep Wagoneer S Trailhawk EV conceptMichael Wayland / CNBCDETROIT — Stellantis' Jeep brand is well known for scaling tough terrains, ...
Three key questions that will shape whether Coach and Michael Kors owners will merge
Pedestrians walk past a Coach store and a Michael Kors store.Scott Olson | Getty ImagesJust a few miles from the ...
Stocks making the biggest moves after hours: Adobe, RH, Oracle and more
Horacio Villalobos | Corbis News | Getty ImagesCheck out the companies making headlines in extended trading:Adobe — Shares plunged more ...
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
Pfizer's experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive ...
Recent News
